Pradaxa 110 mg hard capsules
*Company:
Boehringer Ingelheim LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Pradaxa capsules Patient Alert Card
Risk Minimisation Materials
(Click to Download) Pradaxa Prescriber Guide Primary prevention of VTE
Risk Minimisation Materials
(Click to Download) Pradaxa Prescriber Guide SPAF, DVT PE
Risk Minimisation Materials
(Click to Download) Pradaxa Prescriber guide for paediatric use for the treatment of VTE and prevention of recurrent VTE in paediatric patients (paed. VTE)
Risk Minimisation Materials
Boehringer Ingelheim Limited
Address:
The Crescent Building, , Northwood, Santry, Dublin 9Medical Information E-mail:
medinfo.bra@boehringer-ingelheim.comTelephone:
+353 1 295 9620Fax:
+353 1 816 3642